CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¹Úµ¿¼ö
  • ¼Ò ¼Ó: ºñ´¢±â°ú, Àü¸³¼±¼¾ÅÍ
  • Àü¹®ºÐ¾ß : Àü¸³¼±, ½ÅÀå, ¹æ±¤, °íȯ, Ç×¾ÏÄ¡·á, ±ÙÄ¡¼ö¼ú, ·Îº¿¼ö¼ú, ºê¶óÅ°
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: ·Îº¿¼ö¼ú
  • Àü È­: 1577-4488
  • ÆÑ ½º: ·Îº¿¼ö¼ú
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö: https://blog.naver.com/doctor_park
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
152 (±¹¿Ü)SCIE Influence of Alcohol on Phosphodiesterase 5 inhibitors Use in Middle- to Old-Aged Men: A Comparative Study of Adverse Events
151 (±¹¿Ü)SCI New Sparse Implantation Technique of I-125 Low-Dose-Rate Brachytherapy Using Concomitant Short-Term Hormonal Treatment for Low and Intermediate-Risk Prostate Cancer: An Initial Study of Therapeutic Feasibility
150 (±¹³»)SCIE Impact of Cerebrovascular Disease on Survival Benefits From Local Treatment in Patients With De Novo Metastatic Hormone-Sensitive Prostate Cancer
149 (±¹¿Ü)SCI Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
148 (±¹¿Ü)SCI Predictors of renal function after open and robot-assisted partial nephrectomy: A propensity score-matched study
147 (±¹¿Ü)SCIE Detection of circulating tumour cells and their potential use as a biomarker for advanced renal cell carcinoma.
146 (±¹³»)SCIE Validation of SwimCount¢â, a Novel Home-Based Device That Detects Progressively Motile Spermatozoa: Correlation with World Health Organization 5th Semen Analysis.
145 (±¹¿Ü)SCIE Predictors for De Novo Overactive Bladder after Readjustable Mid-Urethral Sling Procedure in Women with Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency
144 (±¹¿Ü)SCIE Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer
143 (±¹³»)KCI Retrograde balloon dilation as a therapeutic option for post-gynecologic surgery ureteral stricture followed by ureteroureterostomy: a comparative study regarding stricture length
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729